Cytosorbents Corp Stock OTC Bulletin Board
Equities
US23283X2062
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Jun. 28 | Cytosorbents Corporation announced that it expects to receive $20 million in funding | CI |
Jun. 24 | CytoSorbents' Blood Purification Device Gets Approval in Taiwan | MT |
Financials (USD)
Sales 2024 * | 39.52M | Sales 2025 * | 46.83M | Capitalization | 44.63M |
---|---|---|---|---|---|
Net income 2024 * | -20M | Net income 2025 * | -9M | EV / Sales 2024 * | 1.13 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.95 x |
P/E ratio 2024 * |
-2.24
x | P/E ratio 2025 * |
-4.57
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.8% |
Latest transcript on Cytosorbents Corp
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Vincent Capponi
PSD | President | 66 | 02-04-24 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 15-07-13 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Edward Jones
BRD | Director/Board Member | 75 | 07-03-31 |
1st Jan change | Capi. | |
---|---|---|
+0.54% | 204B | |
+4.11% | 178B | |
+28.77% | 156B | |
+31.91% | 113B | |
+1.44% | 64.26B | |
+20.14% | 54.98B | |
-1.86% | 47.44B | |
-9.21% | 36.7B | |
-0.47% | 34.84B |